Claudia Gidea
Overview
Explore the profile of Claudia Gidea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadosh B, Birs A, Flattery E, Stachel M, Hong K, Xia Y, et al.
Clin Transplant
. 2024 Mar;
38(4):e15294.
PMID: 38545881
Background: Recent studies suggest the transplantation of Hepatitis C (HCV) hearts from viremic donors is associated with comparable 1 year survival to nonviremic donors. Though HCV viremia is a known...
2.
Jou S, Mendez S, Feinman J, Mitrani L, Fuster V, Mangiola M, et al.
Nat Rev Cardiol
. 2023 Jul;
21(1):25-36.
PMID: 37452122
Approximately 65 million adults globally have heart failure, and the prevalence is expected to increase substantially with ageing populations. Despite advances in pharmacological and device therapy of heart failure, long-term...
3.
James L, LaSala V, Hill F, Ngai J, Reyentovich A, Hussain S, et al.
JTCVS Tech
. 2023 Feb;
17:111-120.
PMID: 36820336
Objective: This study aimed to evaluate the impact of cardiopulmonary bypass for thoraco-abdominal normothermic regional perfusion on the metabolic milieu of donation after cardiac death organ donors before transplantation. Methods:...
4.
Maidman S, Gidea C, Reyentovich A, Rao S, Saraon T, Kadosh B, et al.
Clin Transplant
. 2022 Jun;
36(7):e14745.
PMID: 35678734
Introduction: ImmuKnow, an immune cell function assay that quantifies overall immune system activity can assist in post-transplant immunosuppression adjustment. However, the utility of pre-transplant ImmuKnow results representing a patient's baseline...
5.
Missed Opportunities in Identifying Cardiomyopathy Aetiology Prior to Advanced Heart Failure Therapy
Aiad N, Elnabawai Y, Li B, Narula N, Gidea C, Katz S, et al.
Heart Lung Circ
. 2022 Feb;
31(6):815-821.
PMID: 35165053
Background: Specific aetiologies of cardiomyopathy can significantly impact treatment options as well as appropriateness and prioritisation for advanced heart failure therapies such as ventricular assist device (VAD) or orthotopic heart...
6.
Chen S, Lester L, Piper G, Toy B, Saputo M, Chan W, et al.
ASAIO J
. 2021 Aug;
68(5):714-720.
PMID: 34380951
Intra-aortic balloon pumps (IABPs) can be used to provide hemodynamic support in patients with end-stage heart failure as a bridge to transplantation (BTT). The IABP is commonly inserted via the...
7.
Comparison of Outcomes of Enoxaparin Bridge Therapy in HeartMate II versus HeartWare HVAD Recipients
Patel M, Ahuja T, Arnouk S, Gidea C, Reyentovich A, Smith 3rd D, et al.
J Cardiovasc Pharmacol Ther
. 2021 Apr;
26(5):473-479.
PMID: 33844604
Background: There is a lack of robust data evaluating outcomes of enoxaparin "bridge" therapy in left ventricular assist device (LVAD) patients. Methods: We performed a retrospective study of HeartMate II...
8.
Pinnelas R, Friedman J, Gidea C, Yuriditsky E, Chinitz L, Cerrone M, et al.
HeartRhythm Case Rep
. 2020 Jul;
6(7):375-377.
PMID: 32695580
No abstract available.
9.
Lewis T, Gidea C, Reyentovich A, Angel L, Lesko M, Pavone J, et al.
Clin Transplant
. 2020 Jul;
34(10):e14030.
PMID: 32632929
We conducted a retrospective review of thoracic transplant recipients (22 heart and 16 lung transplant recipients) prospectively enrolled in a single-center observational study of HCV NAT+ organ transplantation in HCV...
10.
Kadosh B, Pavone J, Wu M, Reyentovich A, Gidea C
J Heart Lung Transplant
. 2020 Jun;
39(8):855-857.
PMID: 32591314
No abstract available.